Neurocrine Biosciences Inc (NBIX)

Inventory turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cost of revenue (ttm)	US$ in thousands	1,043,000	987,200	960,300	928,400	929,000	891,900	868,900	823,200	776,400	731,600	698,000	656,700	583,300	536,300	492,700	445,300	431,200	427,750	397,039	380,571
Inventory	US$ in thousands	57,400	45,800	42,500	37,200	38,300	28,800	31,700	33,400	35,100	37,000	29,300	29,000	30,500	25,500	28,300	30,100	28,000	20,600	22,000	21,200
Inventory turnover		18.17	21.55	22.60	24.96	24.26	30.97	27.41	24.65	22.12	19.77	23.82	22.64	19.12	21.03	17.41	14.79	15.40	20.76	18.05	17.95

December 31, 2024 calculation

Inventory turnover = Cost of revenue (ttm) ÷ Inventory
= $1,043,000K ÷ $57,400K
= 18.17

Neurocrine Biosciences Inc's inventory turnover has shown fluctuation over the periods provided in the data. The inventory turnover ratio measures how efficiently a company manages its inventory by indicating how many times a company sells and replaces its inventory during a specific period.

The inventory turnover ratio for Neurocrine Biosciences Inc ranged from a low of 14.79 on March 31, 2021, to a high of 30.97 on September 30, 2023. A higher inventory turnover is generally preferred as it signifies that inventory is selling quickly, reducing holding costs and potential obsolescence.

The data reveals that Neurocrine Biosciences Inc experienced improvements in inventory turnover from 2020 to 2023, with significant increases in the ratio from September 2021 to March 2023. However, there was a slight decrease in the ratio from June 2023 to December 2024.

Overall, the trend in Neurocrine Biosciences Inc's inventory turnover demonstrates fluctuations but generally shows an improvement and efficient management of inventory levels during the analyzed periods.